
Aimed Alliance sent a letter to Colorado Representative Ken DeGraaf regarding his special session bill, “Prescription Drug Benefit Information Transparency” (HB25B-1012).…
Aimed Alliance sent a letter to Colorado Representative Ken DeGraaf regarding his special session bill, “Prescription Drug Benefit Information Transparency” (HB25B-1012).…
On October 3, the Colorado Prescription Drug Affordability Board (PDAB) voted to establish an upper payment limit (UPL) for Enbrel,…
On October 7, 2025, Aimed Alliance sent a follow-up letter to the U.S. Food and Drug Administration (FDA) regarding the…
Aimed Alliance submitted a comment to the Oregon Prescription Drug Affordability Board (PDAB) urging it to maintain a careful, evidence-based…
Aimed Alliance sent a letter to Colorado Representative Ken DeGraaf’s regarding his special session bill “Prescription Drug Benefit Information Transparency”…
On September 16, 2025, the Food and Drug Administration (FDA) issued a warning that many over-the-counter blood pressure devices lack…
Aimed Alliance has published a new resource highlighting pharmacy benefit manager (PBMs) practices and proposed reforms to ensure transparency in…
Washington, D.C. — June 30, 2025 — The not-for-profit Aimed Alliance, released a comprehensive new report analyzing how state policies…
Aimed Alliance and HR.com have launched a new webpage highlighting our 2024 survey findings; infographic, and webinar for employers and…
The Oregon Prescription Drug Affordability Board is currently reviewing the affordability of 27 selected medications and has requested feedback from…